Skip to main content
Clinical Trials/JPRN-UMIN000005131
JPRN-UMIN000005131
Completed
N/A

Prospective study for correlation between disease progression and detection of T790M in plasma DNA using MBP-QP method in non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitors - Prospective study for correlation between disease progression and T790M detection in plasma DNA in non-small cell lung cancer (HASAT study)

Foundation for Biomedical Research and Innovation0 sites80 target enrollmentMarch 1, 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
on-small cell lung cancer
Sponsor
Foundation for Biomedical Research and Innovation
Enrollment
80
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2011
End Date
January 31, 2014
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Non\-small cell lung cancer patients with EGFR mutations which is related with acquired resistance such as T790M. 2\.Non\-small cell lung cancer patients who is not appropriated for the study determined by physician in charge.

Outcomes

Primary Outcomes

Not specified

Similar Trials